Literature DB >> 11439748

Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.

P G Williams1, A Allard, L Sears, N Dalrymple, A S Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11439748     DOI： 10.1023/a:1005674016014

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN： 0162-3257


× No keyword cloud information.
  12 in total

1.  Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Authors:  S H Willemsen-Swinkels; J K Buitelaar; I A van Berckelaer-Onnes; H van Engeland
Journal:  J Autism Dev Disord       Date:  1999-04

Review 2.  Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives.

Authors:  A Bailey; W Phillips; M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1996-01       Impact factor: 8.982

3.  The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

Authors:  S H Willemsen-Swinkels; J K Buitelaar; H van Engeland
Journal:  Biol Psychiatry       Date:  1996-06-15       Impact factor: 13.382

4.  Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.

Authors:  C Gillberg
Journal:  Dev Med Child Neurol       Date:  1995-03       Impact factor: 5.449

Review 5.  A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism.

Authors:  R S Chamberlain; B H Herman
Journal:  Biol Psychiatry       Date:  1990-11-01       Impact factor: 13.382

6.  Naltrexone in young autistic children: replication study and learning measures.

Authors:  B K Kolmen; H M Feldman; B L Handen; J E Janosky
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-11       Impact factor: 8.829

Review 7.  Autism and known medical conditions: myth and substance.

Authors:  M Rutter; A Bailey; P Bolton; A Le Couteur
Journal:  J Child Psychol Psychiatry       Date:  1994-02       Impact factor: 8.982

8.  Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

Authors:  M P Bouvard; M Leboyer; J M Launay; C Recasens; M H Plumet; D Waller-Perotte; F Tabuteau; D Bondoux; M Dugas; P Lensing
Journal:  Psychiatry Res       Date:  1995-10-16       Impact factor: 3.222

9.  Naltrexone in autistic children: behavioral symptoms and attentional learning.

Authors:  M Campbell; L T Anderson; A M Small; P Adams; N M Gonzalez; M Ernst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-11       Impact factor: 8.829

10.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10
View more
  3 in total

Review 1.  Interventions to facilitate social interaction for young children with autism: review of available research and recommendations for educational intervention and future research.

Authors:  Scott R McConnell
Journal:  J Autism Dev Disord       Date:  2002-10

2.  Oxytocin under opioid antagonism leads to supralinear enhancement of social attention.

Authors:  Olga Dal Monte; Matthew Piva; Kevin M Anderson; Marios Tringides; Avram J Holmes; Steve W C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

Review 3.  Stereotypic behavior in nonhuman primates as a model for the human condition.

Authors:  Corrine K Lutz
Journal:  ILAR J       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.